ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2661

A Ten-Year Retrospective Review of Temporal Artery Biopsy Lengths in Alberta

Raymond Chu1, Caylea Foster 2, Mohsin Ali 3, Todd Chaba 1, Jason Soo 1, Alison Clifford 1, Jan Willem Cohen Tervaert 1 and Elaine Yacyshyn 1, 1University of Alberta, Edmonton, Canada, 2University of Calgary, Calgary, Canada, 3Harvard, Boston, MA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: giant cell arteritis, temporal arteritis and biopsy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Giant Cell Arteritis

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Temporal arteritis or giant cell arteritis (GCA) is a large vessel vasculitis that involves extracranial arteries. The historical gold standard for diagnosis is a temporal artery biopsy (TAB) which has potential for false negativity. Current guidelines recommend biopsy lengths of at least one cm with no suggestion of an upper limit. The purpose of this study is to review all biopsy lengths performed in the province of Alberta, Canada to identify an ideal biopsy length as well as other predictors of a positive diagnosis of GCA.

Methods: A retrospective chart review was performed on patients who had undergone a TAB procedure in 22 sites between January 1st, 2008 to January 1st, 2018.Data extracted included patient’s age sex, levels of inflammatory markers (ESR and CRP), side of biopsy, post-fixation length and final pathological diagnoses. Predictors of positive pathology were modelled using logistic regression. Stata 14.1 (StataCorp) was used for data analysis.

Results: A total of 1203 biopsies were identified over the decade. Median age was 73 (quartile range [QR], 64–80) years, with 806 (67%) female patients. A total of 235 (20%) biopsies were diagnosed as GCA, with median biopsy length of 1.3 cm (QR, 0.9–1.8 cm). Biopsy lengths between sites ranged between 0.8 cm (QR, 0.6–1.1 cm) to 2.2 cm (QR, 1.5–3.3 cm). Univariate analysis noted increased age (odds ratio [OR] 1.04 per year, 95% CI, 1.02–1.05; p < 0.001), ESR (OR 1.01 per unit, 95% CI, 1.01–1.02; p < 0.001), CRP (OR 1.01 per unit, 95% CI, 1.01–1.01; p < 0.001) and biopsy lengths (OR 1.25 per cm, 95% CI, 1.06–1.46; p = 0.007) were associated with positive GCA diagnosis. In multivariate analysis, only age (OR 1.04 per year, 95% CI, 1.02–1.05; p < 0.001) and CRP (OR 1.01 per unit, 95% CI, 1.00-1.01; p < 0.001) remained statistically significant predictors of a positive GCA diagnosis. We noted an increasing odds ratio for a positive biopsy with increasing length of biopsy up until 2.00–2.49 cm (OR 2.79 per cm 95% CI, 1.10 – 7.09).

Conclusion: This study indicates the optimal upper end of temporal artery biopsy length is between 2.00-2.49 cm. We note the highest OR of a positive biopsy is associated with biopsies of this length, with longer biopsies not providing additional diagnostic yield to justify risks. Our study also shows that age, ESR, CRP and TAB length were significant independent predictors of pathological diagnosis.


Disclosure: R. Chu, None; C. Foster, None; M. Ali, None; T. Chaba, None; J. Soo, None; A. Clifford, None; J. Cohen Tervaert, None; E. Yacyshyn, None.

To cite this abstract in AMA style:

Chu R, Foster C, Ali M, Chaba T, Soo J, Clifford A, Cohen Tervaert J, Yacyshyn E. A Ten-Year Retrospective Review of Temporal Artery Biopsy Lengths in Alberta [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/a-ten-year-retrospective-review-of-temporal-artery-biopsy-lengths-in-alberta/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-ten-year-retrospective-review-of-temporal-artery-biopsy-lengths-in-alberta/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology